Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms
- PMID: 28237400
- DOI: 10.1016/j.radonc.2017.02.006
Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms
Abstract
Introduction: Commonly used clinical models for survival prediction after stereotactic radiosurgery (SRS) for brain metastases (BMs) are limited by the lack of individual risk scores and disproportionate prognostic groups. In this study, two nomograms were developed to overcome these limitations.
Methods: 495 patients with BMs of NSCLC treated with SRS for a limited number of BMs in four Dutch radiation oncology centers were identified and divided in a training cohort (n=214, patients treated in one hospital) and an external validation cohort n=281, patients treated in three other hospitals). Using the training cohort, nomograms were developed for prediction of early death (<3months) and long-term survival (>12months) with prognostic factors for survival. Accuracy of prediction was defined as the area under the curve (AUC) by receiver operating characteristics analysis for prediction of early death and long term survival. The accuracy of the nomograms was also tested in the external validation cohort.
Results: Prognostic factors for survival were: WHO performance status, presence of extracranial metastases, age, GTV largest BM, and gender. Number of brain metastases and primary tumor control were not prognostic factors for survival. In the external validation cohort, the nomogram predicted early death statistically significantly better (p<0.05) than the unfavorable groups of the RPA, DS-GPA, GGS, SIR, and Rades 2015 (AUC=0.70 versus range AUCs=0.51-0.60 respectively). With an AUC of 0.67, the other nomogram predicted 1year survival statistically significantly better (p<0.05) than the favorable groups of four models (range AUCs=0.57-0.61), except for the SIR (AUC=0.64, p=0.34). The models are available on www.predictcancer.org.
Conclusion: The nomograms predicted early death and long-term survival more accurately than commonly used prognostic scores after SRS for a limited number of BMs of NSCLC. Moreover these nomograms enable individualized probability assessment and are easy into use in routine clinical practice.
Keywords: Individualized brain metastases; Prognostic models; Stereotactic radiosurgery.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.BMC Cancer. 2017 Nov 21;17(1):774. doi: 10.1186/s12885-017-3763-x. BMC Cancer. 2017. PMID: 29157203 Free PMC article.
-
Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.Radiat Oncol. 2015 Nov 26;10:244. doi: 10.1186/s13014-015-0550-1. Radiat Oncol. 2015. PMID: 26611493 Free PMC article.
-
External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort.J Neurooncol. 2018 Mar;137(1):147-154. doi: 10.1007/s11060-017-2707-2. Epub 2017 Dec 7. J Neurooncol. 2018. PMID: 29218431
-
Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms.Crit Rev Oncol Hematol. 2018 Jun;126:13-18. doi: 10.1016/j.critrevonc.2018.03.018. Epub 2018 Mar 29. Crit Rev Oncol Hematol. 2018. PMID: 29759555 Review.
-
Treatment and prophylaxis for brain metastases from non-small cell lung cancer: whole brain radiation treatment versus stereotactic radiosurgery.Ann Oncol. 2006 Mar;17 Suppl 2:ii71-72. doi: 10.1093/annonc/mdj929. Ann Oncol. 2006. PMID: 16608990 Review. No abstract available.
Cited by
-
Comparison of nomogram and machine-learning methods for predicting the survival of non-small cell lung cancer patients.Cancer Innov. 2022 Aug 30;1(2):135-145. doi: 10.1002/cai2.24. eCollection 2022 Aug. Cancer Innov. 2022. PMID: 38090651 Free PMC article.
-
Development and validation of nomograms to predict early death in non-small cell lung cancer patients with brain metastasis: a retrospective study in the SEER database.Transl Cancer Res. 2023 Mar 31;12(3):473-489. doi: 10.21037/tcr-22-2323. Epub 2023 Mar 21. Transl Cancer Res. 2023. PMID: 37033346 Free PMC article.
-
Open Source Repository and Online Calculator of Prediction Models for Diagnosis and Prognosis in Oncology.Biomedicines. 2022 Oct 23;10(11):2679. doi: 10.3390/biomedicines10112679. Biomedicines. 2022. PMID: 36359199 Free PMC article.
-
Stereotactic radiotherapy for brain metastases in patients with lung cancer; outcome and toxicity in clinical practice.Rep Pract Oncol Radiother. 2022 Jul 29;27(3):410-418. doi: 10.5603/RPOR.a2022.0056. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36186692 Free PMC article.
-
Improved Survival With Surgical Treatment of Primary Lung Lesions in Non-Small Cell Lung Cancer With Brain Metastases: A Propensity-Matched Analysis of Surveillance, Epidemiology, and End Results Database.Front Oncol. 2022 Jul 22;12:888999. doi: 10.3389/fonc.2022.888999. eCollection 2022. Front Oncol. 2022. PMID: 35936705 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
